This presentation is a poster that was presented at the Academy of Psychosomatic Medicine (APM) 2012 Annual Conference held in Atlanta, GA on Nov. 14-18, 2012.Traumatic brain injury (TBI), a common condition seen in both adults and children, can lead to cognitive, social and physical complications. Attention Deficit/Hyperactivity Disorder (ADHD) induced by TBI in children (secondary ADHD or ADHD/TBI) is one consequence that has limited discussion in the literature. This poster reviews the psychopharmacologic treatment options available, their effectiveness, and what is currently under study.https://deepblue.lib.umich.edu/bitstream/2027.42/94209/2/TBI - SN and DG - APM 2012.pdfDescription of TBI - SN and DG - APM 2012.pdf : Poster Presen...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Disorders of attention, memory, and executive function are common sequelae in children who have sust...
Background: There is controversy about whether central nervous system stimulant (CNS) medication is ...
Attention deficit hyperactivity disorder (ADHD), the most common behavioral disorder in children, ma...
The FDA committees and the manufacturers of the most common ADHD drugs have recently modified the pr...
“This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Clinical ...
This journal suppl. entitled: Special Issue: Abstracts of the 30th International Conference on Pharm...
The present study compared executive dysfunction among children with attention-deficit/hyperactivity...
The purpose of this multicenter, prospective, randomized, placebo-controlled study was to evaluate a...
The purpose of this multicenter, prospective, randomized, placebo-controlled study was to evaluate a...
Attentional impairments following traumatic brain injury (TBI) are common, and often significantly d...
Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and adults, with...
Objective . To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and...
Objective: To determine if atomoxetine will improve attention impairment following traumatic brain i...
Background Road traffic accidents are known to be the main cause of traumatic brain injury (TBI). TB...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Disorders of attention, memory, and executive function are common sequelae in children who have sust...
Background: There is controversy about whether central nervous system stimulant (CNS) medication is ...
Attention deficit hyperactivity disorder (ADHD), the most common behavioral disorder in children, ma...
The FDA committees and the manufacturers of the most common ADHD drugs have recently modified the pr...
“This is an Accepted Manuscript of an article published by Taylor & Francis in Journal of Clinical ...
This journal suppl. entitled: Special Issue: Abstracts of the 30th International Conference on Pharm...
The present study compared executive dysfunction among children with attention-deficit/hyperactivity...
The purpose of this multicenter, prospective, randomized, placebo-controlled study was to evaluate a...
The purpose of this multicenter, prospective, randomized, placebo-controlled study was to evaluate a...
Attentional impairments following traumatic brain injury (TBI) are common, and often significantly d...
Attention deficit hyperactivity disorder (ADHD) is common in children, adolescents, and adults, with...
Objective . To evaluate the relationship between attention-deficit hyperactivity disorder (ADHD) and...
Objective: To determine if atomoxetine will improve attention impairment following traumatic brain i...
Background Road traffic accidents are known to be the main cause of traumatic brain injury (TBI). TB...
Methylphenidate (MPH), the most common medication for children with Attention Deficit/Hyperactivity ...
Disorders of attention, memory, and executive function are common sequelae in children who have sust...
Background: There is controversy about whether central nervous system stimulant (CNS) medication is ...